---
Progress in Neurology and Psychiatry,Volume 22, Issue 1, Page 9-11, January/ February/ March 2018. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Source Type: research

---
Progress in Neurology and Psychiatry,Volume 22, Issue 1, Page 5-6, January/ February/ March 2018. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Source Type: research

---
Progress in Neurology and Psychiatry,Volume 22, Issue 1, Page 4-4, January/ February/ March 2018. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Source Type: research

Pharmacological alternatives to antipsychotics to manage BPSD
Non‐pharmacological management remains the initial approach for behavioural and psychological symptoms of dementia (BPSD). However, pharmacological management has a role in specific situations. Here, the authors examine the pharmacological management of elderly patients with dementia and challenging behaviour and aim to raise awareness of the risk of complications associated with first‐ and second‐generation antipsychotic medications. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Raafat Samir Labib Mishriky, Ayman Antoun Reyad Tags: Review Source Type: research

Applying the apprenticeship model to psychiatry: an evaluation
This article assesses the success of an apprenticeship scheme piloted within a mental health setting for fourth year medical students. The results show that it was possible and indeed successful in terms of fulfilling the basic tenets of the apprenticeship model. It was also found to be a novel method of increasing the likelihood of students considering psychiatry as a future career. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Pratibha Nirodi, Hany El ‐Sayeh, Helen Henfrey Tags: Original Research Source Type: research

Use of mirtazapine in children and adolescents
(Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Imran Mushtaq, Piyush Satyawadi Tags: Letter Source Type: research

Recurrent TGA: link to family history?
(Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: AJ Larner Tags: Letter Source Type: research

Serotonin syndrome in asymptomatic Huntington's disease
Serotonin syndrome is a rare and serious condition most often resulting from iatrogenic insult; the prescriber's pen is sometimes the most poisonous. Here, Dr Haffenden and Dr Patel discuss a complex case of serotonin syndrome in a patient with genetically proven, but not yet symptomatic, Huntington's disease and chronic renal impairment. A screening process is proposed to recognise the multitude of precipitating factors, which aligned in this case, and could either alter our prescribing or expedite recognition. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Verity Haffenden, Anish Patel Tags: Case notes Source Type: research

Autonomic dysreflexia in syringomyelia secondary to Chiari malformation
Autonomic dysreflexia is a serious complication of high level spinal cord injury. Here, the authors present a case of autonomic dysreflexia in a patient with non‐traumatic spinal cord pathology and review the incidence of such potentially fatal complications in other neurological conditions involving the high level spinal cord. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Tarek Gaber, Hollie Ringrose Tags: Case notes Source Type: research

Memantine ‐induced bradycardia – a rare adverse reaction
Behavioural and psychological symptoms of dementia, such as aggression or agitation are very frequent in Alzheimer's disease with most guidelines recommending memantine as first‐line pharmacological treatment. Here, the authors describe a patient who developed bradycardia when prescribed memantine and the subsequent changes required to her medication management to avoid further cardiac adverse reactions. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Georgios Mousailidis, Shafalica Bhan ‐Kotwal, Carlo Lazzari, Ahmed Shoka Tags: Case notes Source Type: research

Limbic encephalitis and bipolar affective disorder: a slow awakening
There is increasing evidence for the role of autoimmune encephalitis in the aetiology of psychosis. Here, Dr Lilford and colleagues describe the case of a 74‐year‐old lady who presented as hypomanic almost a year previously and then developed bizarre stereotyped movements, periods of absences and became confused. She was admitted to an old age psychiatric ward and was then subsequently diagnosed with non‐paraneoplastic limbic encephalitis with high levels of voltage‐gated potassium channel complex antibodies. The authors discuss her treatment with immunosuppressive drugs, which resulted in significant clinical impr...
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Philippa Lilford, Hamish Morrison, Elsa Morgan, Rosalind Ward Tags: Case notes Source Type: research

Psychobiotics: bacterial hope for depression?
Increasing evidence links the microbiome's composition with several psychiatric and neurological diseases, including autism, schizophrenia, attention deficit hyperactivity disorder, Parkinson's disease, Alzheimer's disease and multiple sclerosis – Mark Greener investigates. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Mark Greener Tags: News review Source Type: research

Cladribine tablets and multiple sclerosis: NICE technology appraisal
Cladribine is the first disease modifying treatment (DMT) for relapsing remitting multiple sclerosis (RRMS) that progressed straight to a positive final recommendation in the NICE appraisal process. The final recommendations were published in December 2017.1 An agreement between NHS England and Merck, the manufacturer of cladribine (Mavenclad), will allow MS patients who are suffering from highly active or rapidly evolving RRMS to access the drug. Here, the authors discuss the clinical and economic considerations for cladribine usage. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - February 22, 2018 Category: Neurology Authors: Tarek Gaber, Clare Shippen Tags: Comment Source Type: research

The gut ‐brain connection: the developing science of the microbiome
Our commentaries from the Primary Care Neurology Society (P‐CNS) provide a primary care perspective on the neurology articles in Progress. Here Dr Bindemann and Dr Ali consider ‘Psychobiotics: bacterial hope for depression’ (see page 9). (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - January 1, 2018 Category: Neurology Authors: Neil Bindemann, Saqib Ali Tags: Comment Source Type: research

For everything there is a season: biological rhythms in psychiatry
A new study suggests that a circadian clock gene expressed in skeletal muscle may influence recovery from sleep deprivation, in mice at least. A greater understanding of such mechanisms may provide insights into one of the basic rhythms that rules our lives and disorders associated with disrupted sleep patterns. (Source: Progress in Neurology and Psychiatry)
Source: Progress in Neurology and Psychiatry - November 27, 2017 Category: Neurology Authors: Mark Greener Tags: News review Source Type: research